358 related articles for article (PubMed ID: 17874229)
1. [Testicular cancer--is there an indication for adjuvant or neoadjuvant systemic therapy?].
Langenkamp S; Albers P
Urologe A; 2007 Oct; 46(10):1389-90, 1392-4. PubMed ID: 17874229
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
3. [Management of localized germ-cell tumours of the testis].
Loriot Y; Fizazi K
Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
[TBL] [Abstract][Full Text] [Related]
4. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
Sparwasser C; Treiber U; Beckert R; Pust RA
Urologe A; 1995 Nov; 34(6):444-8. PubMed ID: 8848854
[TBL] [Abstract][Full Text] [Related]
5. [Inductive systemic therapy of urological tumors with curative intent].
vom Dorp F; Krege S; Rübben H
Urologe A; 2007 Oct; 46(10):1400-3. PubMed ID: 17874061
[TBL] [Abstract][Full Text] [Related]
6. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
7. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for stage I non-seminomatous testicular cancer.
Abratt RP; Pontin AR; Barnes RD; Reddi BV
S Afr Med J; 1994 Sep; 84(9):605-7. PubMed ID: 7530863
[TBL] [Abstract][Full Text] [Related]
9. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
Vidal AD; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
Ann Oncol; 2015 Feb; 26(2):374-7. PubMed ID: 25392157
[TBL] [Abstract][Full Text] [Related]
11. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Amato RJ; Ro JY; Ayala AG; Swanson DA
Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
[TBL] [Abstract][Full Text] [Related]
12. Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
Göbel U; Calaminus G; Haas R; Teske C; Schönberger S; Schneider DT; Leuschner I; Harms D
Klin Padiatr; 2014 Nov; 226(6-7):316-22. PubMed ID: 25431864
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
Djaladat H; Nichols C; Daneshmand S
Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
Studer UE; Fey MF; Calderoni A; Kraft R; Mazzucchelli L; Sonntag RW
Eur Urol; 1993; 23(4):444-9. PubMed ID: 7687549
[TBL] [Abstract][Full Text] [Related]
16. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
[TBL] [Abstract][Full Text] [Related]
17. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
18. [Is risk-oriented therapy in stage I non-seminoma tumor advisable?].
Krege S; Rübben H
Urologe A; 1993 May; 32(3):171-5. PubMed ID: 8390119
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for testicular cancer.
Xiao H; Sheinfeld J; Motzer RJ
Surg Oncol Clin N Am; 1997 Oct; 6(4):863-78. PubMed ID: 9309098
[TBL] [Abstract][Full Text] [Related]
20. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
